| __timestamp | Amphastar Pharmaceuticals, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 11032000 |
| Thursday, January 1, 2015 | 251519000 | 4050000 |
| Friday, January 1, 2016 | 255165000 | 11043000 |
| Sunday, January 1, 2017 | 240175000 | 327000 |
| Monday, January 1, 2018 | 294666000 | 8198000 |
| Tuesday, January 1, 2019 | 322357000 | 35219000 |
| Wednesday, January 1, 2020 | 349846000 | 46551000 |
| Friday, January 1, 2021 | 437768000 | 439442000 |
| Saturday, January 1, 2022 | 498987000 | 722683000 |
| Sunday, January 1, 2023 | 644395000 | 232284000 |
In pursuit of knowledge
In the dynamic world of biotechnology, Amphastar Pharmaceuticals, Inc. and Dynavax Technologies Corporation have charted intriguing revenue trajectories over the past decade. From 2014 to 2023, Amphastar's revenue surged by over 200%, peaking at approximately $644 million in 2023. This growth reflects a consistent upward trend, with significant gains in 2021 and 2022.
Conversely, Dynavax experienced a rollercoaster ride. After a modest start in 2014, its revenue skyrocketed by 6,500% to a peak of $723 million in 2022, driven by strategic innovations and market expansions. However, 2023 saw a sharp decline to $232 million, highlighting the volatility inherent in biotech markets.
These contrasting paths underscore the diverse challenges and opportunities within the sector, offering valuable insights for investors and industry watchers alike.
Who Generates More Revenue? Johnson & Johnson or Dynavax Technologies Corporation
Who Generates More Revenue? AbbVie Inc. or Dynavax Technologies Corporation
Revenue Showdown: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Biogen Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Genmab A/S and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
Annual Revenue Comparison: Perrigo Company plc vs Dynavax Technologies Corporation
ACADIA Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Bausch Health Companies Inc. or Dynavax Technologies Corporation?
Amphastar Pharmaceuticals, Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Dynavax Technologies Corporation and MiMedx Group, Inc. Performance Compared